Everdrone Secures SEK 36 Million, Propelling Drone-Based Emergency Healthcare Across Europe
March 20, 2026, 3:34 pm
Everdrone secured SEK 36 million in new funding. This investment dramatically advances its autonomous drone service for emergency healthcare. Drones deliver vital defibrillators directly to cardiac arrest patients. Sciety led the significant funding round. The capital fuels Everdrone's ambitious commercial expansion across multiple European markets. This critical technology profoundly enhances rapid emergency response and improves cardiac arrest survival rates. Everdrone's system is already operational in Sweden and France, with further implementations underway. This innovation marks a pivotal step in urgent medical delivery. It redefines time-critical medical interventions globally.
Autonomous drones are transforming emergency healthcare. Swedish firm Everdrone recently secured SEK 36 million in new funding. This investment propels its innovative drone service. The company aims for commercial expansion across Europe. It focuses on critical time-sensitive medical interventions.
Sudden cardiac arrest remains a grave concern. Hundreds of thousands suffer annually in Europe. Most cases occur outside hospitals. Immediate defibrillation drastically increases survival chances. Traditional emergency services often face delays. Ambulances cannot always arrive swiftly. Access to automated external defibrillators (AEDs) remains limited in homes. Everdrone addresses this critical gap.
The company deploys autonomous drones. These drones integrate directly into the emergency response chain. They dispatch in parallel with ambulances. Their mission: rapid delivery of AEDs. This ensures life-saving equipment reaches patients quickly. The system also supports emergency dispatchers. It provides real-time video surveillance of incident sites.
Everdrone's technology is advanced. It combines proprietary drones with sophisticated software. This enables autonomous operations. Drones fly in densely populated urban areas. They operate beyond visual line of sight. This is a challenging regulatory feat. Few operators in Europe have achieved it. The solution optimizes for time-critical medical transport. It applies to various acute medical situations.
The company's impact is already profound. Everdrone operates the world’s first operational drone service for cardiac arrest. It is integrated into the emergency chain. This service functions in Sweden's Västra Götaland Region. Region Stockholm has also procured the technology. An operational launch there is set for 2026. Normandy Region in France actively uses the service.
International attention has mounted. Everdrone became the first company globally. It contributed to saving a life using an autonomous drone. Leading medical journals, including The Lancet, have featured its work. The New England Journal of Medicine also highlighted its success. This recognition underscores the technology's clinical relevance.
Interest in drone-based solutions is surging. Regions seek new ways to cut response times. They aim to improve coverage. This applies to both urban and rural settings. Everdrone’s system offers this capability. It scales to meet diverse geographic needs. The company also foresees offering its technology standalone. Other organizations could utilize its drones for critical transport needs.
Sciety, an investment firm, led the funding round. It identified Everdrone as a key growth company. Sciety focuses on life science and health tech. They see a clear, documented need for Everdrone's solution. Sciety serves as a long-term capital partner. The firm provides more than just funds. It contributes industry expertise. It offers a valuable network. This enhances Everdrone's visibility. Such support accelerates growth and market expansion.
The new capital will drive validation. It will refine Everdrone's operational model within emergency services. The company will further develop its technology platform. This includes expanding complementary service offerings. Everdrone plans to deepen its European market presence. New markets are a strategic priority.
This funding round marks a significant milestone. It allows Everdrone to strengthen its foundation. The company can continue building its enterprise. It will expand its footprint across Europe. The vision is clear: safer, faster emergency medical care. Autonomous drones are making this vision a reality. They are revolutionizing emergency response. They offer a new paradigm for life-saving interventions.
Autonomous drones are transforming emergency healthcare. Swedish firm Everdrone recently secured SEK 36 million in new funding. This investment propels its innovative drone service. The company aims for commercial expansion across Europe. It focuses on critical time-sensitive medical interventions.
Sudden cardiac arrest remains a grave concern. Hundreds of thousands suffer annually in Europe. Most cases occur outside hospitals. Immediate defibrillation drastically increases survival chances. Traditional emergency services often face delays. Ambulances cannot always arrive swiftly. Access to automated external defibrillators (AEDs) remains limited in homes. Everdrone addresses this critical gap.
The company deploys autonomous drones. These drones integrate directly into the emergency response chain. They dispatch in parallel with ambulances. Their mission: rapid delivery of AEDs. This ensures life-saving equipment reaches patients quickly. The system also supports emergency dispatchers. It provides real-time video surveillance of incident sites.
Everdrone's technology is advanced. It combines proprietary drones with sophisticated software. This enables autonomous operations. Drones fly in densely populated urban areas. They operate beyond visual line of sight. This is a challenging regulatory feat. Few operators in Europe have achieved it. The solution optimizes for time-critical medical transport. It applies to various acute medical situations.
The company's impact is already profound. Everdrone operates the world’s first operational drone service for cardiac arrest. It is integrated into the emergency chain. This service functions in Sweden's Västra Götaland Region. Region Stockholm has also procured the technology. An operational launch there is set for 2026. Normandy Region in France actively uses the service.
International attention has mounted. Everdrone became the first company globally. It contributed to saving a life using an autonomous drone. Leading medical journals, including The Lancet, have featured its work. The New England Journal of Medicine also highlighted its success. This recognition underscores the technology's clinical relevance.
Interest in drone-based solutions is surging. Regions seek new ways to cut response times. They aim to improve coverage. This applies to both urban and rural settings. Everdrone’s system offers this capability. It scales to meet diverse geographic needs. The company also foresees offering its technology standalone. Other organizations could utilize its drones for critical transport needs.
Sciety, an investment firm, led the funding round. It identified Everdrone as a key growth company. Sciety focuses on life science and health tech. They see a clear, documented need for Everdrone's solution. Sciety serves as a long-term capital partner. The firm provides more than just funds. It contributes industry expertise. It offers a valuable network. This enhances Everdrone's visibility. Such support accelerates growth and market expansion.
The new capital will drive validation. It will refine Everdrone's operational model within emergency services. The company will further develop its technology platform. This includes expanding complementary service offerings. Everdrone plans to deepen its European market presence. New markets are a strategic priority.
This funding round marks a significant milestone. It allows Everdrone to strengthen its foundation. The company can continue building its enterprise. It will expand its footprint across Europe. The vision is clear: safer, faster emergency medical care. Autonomous drones are making this vision a reality. They are revolutionizing emergency response. They offer a new paradigm for life-saving interventions.